Chlamydia trachomatis and herpes simplex virus 2 infection in vul var intraepithelial neoplasia associated with human papillomavirus

Background: The role of viral and bacterial co-infection is stressed in VIN. A view that VIN is a sexually transmitted disease made the area of research larger and stimulated scientists to seek other sexually transmitted factors, among which Chlamydia trachomatis and Herpes simplex are frequently examined.

Purpose: The aim of the study was to evaluate the frequency of occurrence of HPV DNA and the frequency of co-infection with Herpes virus type 2 and Chlamydia trachomatis in VIN.

Material and methods: We identified archival diagnostic phase tissue specimens from 41 cases of vulvar intraepithelial neoplasia III. From the same paraffin blocks containing material from the margins of surgical sections during vulvectomy, normal epithelial tissue fragments were collected. They constituted the control group. Lesion characteristics were examined in comparison with the presence of HPV DNA, HSV-2 and Chlamydia trachomatsis. Identification was performed using PCR.

Results: In the study group HPV infection was found in 75.6% of cases. In 73% of cases it was HPV 16. In the control group we found HPV 16 DNA in only one case (2.43%). In the HPV positive study group HPV 16 was found in 30 (30/31) cases. In only one case (1/31) it was HPV 18 type. In the study group of 41 cases with VIN, HSV-2 infection was found in six cases (14.63%). In comparison with the control group (9.75%) the difference was not statistically significant. The frequency of occurrence of Chlamydia trachomatis in the analyzed study material was 14.63% (6/41) and in the control group it was 9.75% (4/41). The difference was not statistically significant. Statistical analyses of correlations between the occurrence of DNA HPV and HSV-2 as well as of HPV and Chlamydia trachomatis showed no correlation in either case.

Conclusion: No correlation was found between the frequency of occurrence of HPV and HSV-2 and HPV and Chlamydia trachomatis in either group.

VIN; HPV; HSV-2; Chlam汕a trachomatis; Vulvar intraepithelial neoplasia

[1] Flowers L.C., Wistuba E.A., Scurry J., Muller C.Y., Ashfaq R., Miller D.S. et al.: "Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas". J. Soc. Gynecol. Invest., 1999, 6, 213.

[2] zur Hausen H.: "Papillomaviruses and cancer: from basic studies to clinical application". Nature Rev., 2002, 2, 342.

[3] Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M.: "The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53". Cell., 1990, 63, 1129.

[4] Munger K., Basile J.R., Duensing S., Eichten A., Gonzales S.L., Grace M., Zacny V.L.: "Biological activities and molecular targets of the human papillomavirus E7 oncoprotein". Oncogene, 2001, 20, 7888.

[5] Hart W.R.: "Simplex (differentiated) VIN: an underappreciated threat". Contemp. Obstet. Gynaecol., 2003, 48, 59.

[6] Hart W.R.: "Vulvar intraepithelial neoplasia; historical aspects and current status". Int. J. Pathol., 2001, 20, 16.

[7] Hart W.R., Young R.H., Dail D.H.: "Tumors and related lesions of the female genital tract; based on the proceedings of the 56th Annual Anatomic Pathology Slide Seminar of the American Society of Clinical Pathologists". Dallas, ASCP Press, 1991.

[8] Meyers C., Andreansky S.S., Courtney R.J.: "Replication and interaction of herpes simplex virus and human papillomavirus in differencing host epithelial tissue". Virology, 2003, 315, 43.

[9] Tucker R.A., Johnson P.R., Reeves W.: "Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results". J. Viral. Methods, 1993, 43, 321.

[10] IARC. Human Papillomaviruses. IRAC monographs on the evaluation of carcinogenic risks to humans. Vol. 64, Lyon, IARC, 1995.

[11] Bjorge T.B., Dillner J., Anttila T.: "Prospective sero-epidemiological study of role of human papillomavirus in non-cervical anogenital cancer". Br. Med. J., 1997, 315, 646.

[12] Hildesheim A., Han C.-L., Brinton L.: "Human papillomavirus type 16 and risk of pre-invasive and invasive vulvar cancer: results from a seroepidemiological case-control study". Obstet. Gynecol., 1997, 90, 748.

[13] Planner R.S., Hobbs H.B.: "Intraepithelial and invasive neoplasia of the vulva in association with human papillomavirus infection". J. Reprod. Med., 1988, 35, 503.

[14] Hording U., Junge J., Poulsen H., Lundvall F.: "Vulvar Intraepithelial Neoplasia II: a viral disease of undetermined progressive potential". Gynecol. Oneal., 1995, 56, 276.

[15] Adamek K., Szczudrawa A., Basta A., Wsp6listnienie: "VIN i raka inwazyjnego sromu ze sr6dnablokow􀅾 neoplazja i rakiem inwazyjnym szyjki macicy i lub pochwy, a infekcja HPV w obrebie dolnego odcinka narz􀆀u rodnego". Gin. Pol., 2003, 9, 657.

[16] Radolakis A., Di吐omanolis E., Vlachos G., Iconomou Th., Protopappas A., Stefanidis C. et al.: "Vulvar intraepithelial neoplasia (VIN) - diagnostic and therapetic challenges". Eur. J. Gynecol. Oneal., 2003, 24, 317.

[17] van der Avoort J.A., Shirango H., Hoevenaars B. M.,Greffe J.M., de Hullu l.A.,de Wilde P.C. et al.: "Vulvar Squainous cell carcinoma is a multifocale disease following two separate and independent pathways". Int. J. Gynecol. Pathol., 2006, 25, 22.

[18] Hillemanns P., Wang X.: "Integration of HPV-16 and HPV-18 DNA in vulvar intraepitehelial neoplasia". Gynecol. Oneal., 2006, 100, 276.

[19] Lehtinen M., Koskela P., Jellum E., Bloigu A., Antilla T., Hallmans G., Luukkaala T. et al.: "Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries". Am. J. Epidemiol., 2002, 156, 687.

[20] Tran-Thanh D., Provencher D., Koushik A., Duarte-Franco E., Kessous A., Drouin P. et al.: "Herpes simplex virus type II is not cofactor to human papillomavirus in cancer of the uterine cervix". Am. J. Obstet. Gynecol., 2003, 188, 129.

[21] Smith J.S., Herrero R., Bosetti C., Munoz N., Bosch F.X., ElufNeto J., Castellsouge X. et al.: "Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer". J. Natl. Cancer Inst., 2002, 94, 1604.

[22] Costa S., Rotola A., Terzano P., Poggi M.G., Di Luca D., Aurelian L. et al.: "Search for herpes simplex virus 2 and human papillomavirus genetic expression in vulvar neoplasia". J. Reprod. Med., 1990, 35, 1108.

[23] K wasniewska A., Semczuk M., Kuzma D., Teresinska D.,Gozdzicka-J6zefiak A.: "Czestosc wystepowania HPV i Chlamydia trachomatis w kom6rkach sromu kobiet asymptomatycznych". Pol. Przeg. Gin. Pol., 2003, 3, 139.

[24] YangY.Y., Koh W., Tsai H., Wong E.F., Lin S.J., Yang C.C.: "Correlation of viral factors with cervical cancer in Taiwan". J. Microbiol. lmmunol. Infect., 2004, 37, 282.